Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | IL-4 | 105.0 | 53 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | IL-4 | 114.0 | 69 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | IL-4 | 90.0 | 56 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | IL-4 | 95.0 | 53 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | IL-4 | 105.5 | 70 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | IL-4 | 105.0 | 63 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | IL-4 | 117.0 | 67 | |
RA2159 | TNF-a | 100 | ng/mL | 4 | IL-4 | 136.0 | 69 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | IL-4 | 106.0 | 49 | |
N2645 | TNF-a | 100 | ng/mL | 4 | IL-4 | 114.0 | 59 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | IL-4 | 110.0 | 59 | |
RA2708 | TNF-a | 100 | ng/mL | 4 | IL-4 | 104.0 | 43 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 4 | IL-4 | 26.5 | 56 | ||||
RA2159 | IKK16 | 2.0 | uM | 4 | IL-4 | 26.0 | 51 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 4 | IL-4 | 23.5 | 56 | ||||
N2645 | IKK16 | 2.0 | uM | 4 | IL-4 | 25.0 | 41 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 4 | IL-4 | 23.0 | 59 | ||||
RA2708 | IKK16 | 2.0 | uM | 4 | IL-4 | 24.0 | 52 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 4 | IL-4 | 20.5 | 62 | ||||
RA2159 | 4 | IL-4 | 27.0 | 67 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 4 | IL-4 | 20.0 | 39 | ||||
N2645 | 4 | IL-4 | 22.0 | 73 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 4 | IL-4 | 22.5 | 48 | ||||
RA2708 | 4 | IL-4 | 21.0 | 62 | |||||||
RA2159 | 4 | IL-4 | 24.0 | 50 |